Dr. Marta Ascione | Health Sciences | Best Researcher Award

Dr. Marta Ascione | Health Sciences | Best Researcher Award

Dr. Marta Ascione, Vascular Surgery Resident, β€œSapienza” University of Rome, Italy

πŸ‘©β€βš•οΈ Dr. Marta Ascione is an Italian vascular surgery resident at Policlinico Umberto I, “Sapienza” University of Rome. With a strong academic background and international experience, she is recognized for her work in vascular surgery, including innovative approaches to limb ischemia and vascular emergencies. Dr. Ascione has been involved in prestigious research collaborations, contributing to multicentric studies and presenting her findings at international conferences. Fluent in Italian, English, and Spanish, she continues to expand her expertise in vascular surgery through active participation in global projects and clinical research.

Profile πŸ§‘β€πŸ”¬

Orcid

Googlescholar

Based on the detailed information provided, here is a research profile for Dr. Marta Ascione, emphasizing her strengths, areas for improvement, and a conclusion regarding the “Best Researcher Award”:

Strengths for the Award πŸ’ͺπŸ†

Educational Excellence:

Dr. Ascione graduated with a Medicine and Surgery Degree from Campus BioMedico University of Rome, achieving a final vote of 110/110 cum Laude. She is currently a resident in Vascular Surgery at “Sapienza” University of Rome, showcasing a strong academic foundation and commitment to her specialty.

International Experience and Training:

She has participated in prestigious international programs, including a trainee position at Hospital de Clinic, Barcelona, and an elective program under Erasmus+ at the Vascular Surgery department. Her exposure to global practices enriches her perspective and expertise in vascular surgery.

Research Contributions:

Dr. Ascione has been involved in several notable research projects, such as the PEACE registry and the CEUS Collaborative Study Group. Her work covers diverse areas within vascular surgery and endovascular treatments, reflecting her active engagement in advancing the field.

Presentations and Publications:

She has presented her research at several prominent conferences, including SICVE, ESVS, and SITE. Additionally, she has published multiple articles in indexed journals such as Biomedicines and Diagnostics, demonstrating her ability to contribute valuable knowledge to the scientific community.

Awards and Recognition:

Dr. Ascione received the Best Oral Poster Presentation award at the SITE 23rd International Symposium for her work on steroid treatment outcomes. This recognition highlights the impact and quality of her research.

Professional Involvement:

Her roles as a reviewer for journals like BMC Surgery and CVIR indicate her peer recognition and involvement in shaping the research landscape in vascular surgery.

Areas for ImprovementΒ  πŸš€πŸ“ˆ

Broaden Research Scope:

While Dr. Ascione’s focus is strong in vascular surgery, exploring interdisciplinary research or other subspecialties within surgery could broaden her expertise and impact.

Leadership in Major Research Projects:

Taking on more prominent leadership roles in large-scale, multi-center research projects could further enhance her research profile and visibility.

Increased Collaboration:

Expanding collaborations with researchers and institutions outside her immediate field could lead to innovative approaches and interdisciplinary research opportunities.

Publications in High-Impact Journals:

Publishing in top-tier journals with higher impact factors could increase the visibility and influence of her research findings.

Education

πŸŽ“ Dr. Marta Ascione obtained her Medicine and Surgery Degree in 2022 from the Campus BioMedico University of Rome, graduating with honors (110/110 cum Laude). Her thesis, titled “Acute Limb Ischemia in COVID-19 Patients: An International Multicentric Study VASCC”, was conducted in collaboration with the University of Colorado and Policlinico Universitario Fondazione Agostino Gemelli. Currently, she is a vascular surgery resident at “La Sapienza” University of Rome.

Experience

πŸ’Ό Dr. Ascione’s experience spans multiple esteemed institutions, including an Erasmus+ training stint at the Vascular Surgery Department of Hospital Clinic de Barcelona under Prof. Victor Riambau. She has worked extensively in outpatient, operation theater, and ward activities, specializing in sutures, wound care, and vascular diagnostic procedures. Additionally, Dr. Ascione is a reviewer for renowned journals like BMC Surgery and CardioVascular and Interventional Radiology.

Research Interest

πŸ”¬ Dr. Ascione’s research focuses on vascular surgery innovations, particularly in treating complex vascular conditions such as limb ischemia and mesenteric artery diseases. She is involved in international research collaborations, including multicentric studies on endovascular treatments and vascular surgery outcomes. Her work aims to improve clinical practices through evidence-based research and cutting-edge surgical techniques.

Awards

πŸ† In 2023, Dr. Marta Ascione won the Best Oral Poster Presentation Award at the SITE – 23rd International Symposium in Barcelona for her research on the complete regression of superior mesenteric artery hematoma after steroid treatment. Her dedication to vascular surgery has earned her recognition in various international conferences.

Publication Top notes πŸ“

High-Grade Infection after Branched Endovascular Aortic Repair in Patient with Recent COVID-19 Hospitalization

Open Surgical Conversion of Popliteal Endograft Infection: Case Reports and Literature Review

Long-Term Results of Surgical Treatment for Popliteal Artery Entrapment Syndrome

Safety and Effectiveness of a Single Prostyle Vascular Preclose Technique in Patients Undergoing Endovascular Procedures: A Single-Center Prospective Study

Gluteal Artery Access to Embolize False Lumen of Type B Aortic Dissection in Marfan Patient

Clinical and Radiological Outcomes of Accessory Renal Artery Exclusion during Endovascular Repair of Abdominal Aortic Aneurysms

Isolated Intramural Hematoma of Superior Mesenteric Artery: Case Reports and a Review of Literature

Conclusion βœ¨πŸ”Β 

Dr. Marta Ascione is a highly accomplished and promising researcher with a solid educational background, international training, and a growing portfolio of impactful research. Her achievements, including awards, significant publications, and active roles in research and professional societies, demonstrate her potential for making substantial contributions to the field of vascular surgery.

While there are opportunities for further growth in terms of broadening her research focus and increasing collaboration, her current achievements and dedication make her a deserving candidate for the “Best Researcher Award.” Her ongoing contributions to vascular surgery and her commitment to advancing medical knowledge position her well for continued success in her career.

Dr. Mona Kamal Saadeldin | Pharmacology | Best Researcher Award

Dr. Mona Kamal Saadeldin | Pharmacology | Best Researcher Award

Dr. Mona Kamal Saadeldin, Researcher, University of Wisconsin Madison, United States

🌟 Dr. Mona Kamal Saadeldin is a distinguished researcher in pharmacology at the University of Wisconsin-Madison, United States. Her pioneering work in drug development and therapeutic interventions has earned her the prestigious Best Researcher Award πŸ†. With a passion for advancing medical science, Dr. Saadeldin’s research focuses on novel treatments to improve patient outcomes πŸ’Š. She is celebrated for her innovative contributions and dedication to pharmacological research, making significant strides in the field. Her outstanding achievements and commitment to science continue to inspire and pave the way for future breakthroughs πŸ”¬.

PROFILE πŸ“

Googlescholar

EDUCATION πŸŽ“

πŸŽ“ Dr. Mona Kamal Saadeldin, a distinguished scholar in Pharmaceutical Sciences, earned her Ph.D. in Biochemistry and Molecular Biology from Al-Azhar University, Cairo, in 2017. She holds two M.Sc. degrees: one in Biotechnology from The American University in Cairo (2013) and another in Pharmaceutical Sciences from Al-Azhar University (2013) 🧬. Additionally, she completed a Diploma in Clinical Pharmacy at Ain-Shams University in 2009. Her academic journey began with a B.Sc. in Pharmaceutical Sciences from Ain-Shams University in 2006 πŸ§ͺ. Dr. Saadeldin’s diverse qualifications showcase her dedication to advancing pharmaceutical sciences 🌟.

RESEARCH EXPERIENCE πŸ”¬

🌟 Dr. Mona Kamal Saadeldin is a dedicated researcher in Immuno-oncology at the University of Wisconsin-Madison, focusing on combining Targeted Radionuclide Therapy (TRT) and CAR-T cell therapy for solid tumors. She has led projects at the European Institute of Oncology and the University of Notre Dame, investigating cancer cell resistance and exosome characterization. πŸ§¬πŸ’‰ In Egypt, Dr. Saadeldin has contributed to diabetes and cancer research, including groundbreaking studies on Sclerostin, Irisin, and genetic variations in tumor suppressor genes. πŸ“šπŸ§ͺ As an educator, she has supervised and trained students, fostering future scientific innovation. πŸŒΏπŸ‘©β€πŸ«

CONFERENCE POSTER PRESENTATIONS πŸ“Š

Dr. Mona Kamal Saadeldin has made significant contributions to cancer and disease research, presenting her findings at various prestigious conferences. Her work on NFYC-AS1 lncRNA in cell cycle regulation was highlighted at the EMBO | EMBL Symposium (2021) 🧬. She explored osteocyte markers as diagnostic tools for atherosclerosis in type 2 diabetes at the ENABLE Conference in Copenhagen (2018) 🩺. Additionally, Dr. Saadeldin investigated soluble P-selectin levels as markers for diabetic nephropathy at the ESEO Conference (2018) πŸ’‰. Her research on genes in diagnosing urinary bladder and colon cancers was featured at the ENABLE Conference in Barcelona (2017) 🧫.

PROFESSIONAL MEMBERSHIPS 🀝

πŸŽ“ Dr. Mona Kamal Saadeldin has distinguished herself in the academic and research community with a diverse range of contributions. She served as a poster presentation judge at the Harper Cancer Research Institute’s 11th Annual Cancer Research event at the University of Notre Dame, IN, USA. πŸ“š Dr. Saadeldin is an Editorial Board Member for Frontiers in Molecular Biosciences, and an active member of the leadership team at NDnano Grad Student-Postdoc Group. πŸ“ She is the Main Guest Editor for a Methods Collection in JOVE and Co-guest Editor for a Special Issue in Cancers. Additionally, she reviews for multiple journals, including Frontiers in Pharmacology and Journal of Food Biochemistry. 🌟

AWARDS πŸ†

πŸŽ“ Dr. Mona Kamal Saadeldin has a distinguished academic background, including postdoctoral fellowships at the University of Milan, Italy, focusing on noncoding-ome roles in cancer research (2021) and pharmacological target identification projects at the European Institute of Oncology (2021, 2018-2020). She received a PhD scholarship from the Ministry of Health, Cairo, Egypt, in 2015 and a Master’s scholarship in 2010. Additionally, Dr. Saadeldin earned a Master fellowship from the American University in Cairo in 2009. πŸŒŸπŸ”¬ Her work contributes significantly to oncology and neurological research. πŸ§¬πŸ’Ό

PUBLICATION TOP NOTES πŸ“š

Anti-diabetic effects of fenugreek (Trigonella foenum-graecum): A comparison between oral and intraperitoneal administration – an animal study

Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis

Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study

Effects of Turmeric (Curcuma longa) Extract in streptozocin‐induced diabetic model

Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition

Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition

A critical review of chloroquine and hydroxychloroquine as potential adjuvant agents for treating people with cancer

Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside

Thermal stability of a mercuric reductase from the Red Sea Atlantis II hot brine environment as analyzed by site-directed mutagenesis

Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer